Area of research
Infectious Diseases · Virology
Research interest
Research interests include HIV/AIDS drug development and treatment, HIV Research and Treatment, HIV/AIDS Research and Interventions, and HIV-related health complications and treatments.
Care interruptions and mortality among adults in Europe and North America
Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial
Evaluation of Cross-Immunity to the Mpox Virus Due to Historic Smallpox Vaccination
Pillars of long-term antiretroviral therapy success
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
Virological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V: the LAMRES study
SARS-CoV-2 Specific Immune Response and Inflammatory Profile in Advanced HIV-Infected Persons during a COVID-19 Outbreak
The role of Lung Ultrasound in the diagnosis of SARS-COV-2 disease in pregnant women
Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males
The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity
GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population
Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study
Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study
An Inflammatory Profile Correlates With Decreased Frequency of Cytotoxic Cells in Coronavirus Disease 2019
COVID-19 disease—Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study
COVID‐19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS‐CoV‐2
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies
Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHERE
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
Defining cerebrospinal fluid HIV RNA escape
Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients